Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Palomino Laboratories (PALX) Gains from Investment Securities (2025)

Palomino Laboratories recorded quarterly Gains from Investment Securities of $1.5 million in Q3 2025, down 25.0% quarter-over-quarter from $2.0 million in Q1 2025.

Palomino Laboratories' Gains from Investment Securities history runs 1 years deep, the most recent figure standing at $1.5 million for Q3 2025.

  • In Q3 2025, Gains from Investment Securities changed N/A year-over-year to $1.5 million; the TTM figure through Sep 2025 stood at $1.5 million (changed N/A YoY), while the FY2024 annual figure was $58.0, changed 0.0% from the prior year.
  • Gains from Investment Securities came in at $1.5 million for Q3 2025 at Palomino Laboratories, down from $2.0 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $2.0 million in Q1 2025 to a low of $1.5 million in Q3 2025.

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 729,168.00
Sep 30, 2025 729,168.00
Mar 31, 2025 1.50 Mn
Mar 31, 2025 1.50 Mn